Logo image of BHM

BLUEROCK HOMES TRUST INC (BHM) Stock Fundamental Analysis

NYSEARCA:BHM - NYSE Arca - US09631H1005 - REIT - Currency: USD

13.5  +0.21 (+1.58%)

Fundamental Rating

2

Overall BHM gets a fundamental rating of 2 out of 10. We evaluated BHM against 20 industry peers in the Residential REITs industry. Both the profitability and financial health of BHM have multiple concerns. BHM is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BHM had negative earnings in the past year.
BHM had a positive operating cash flow in the past year.
BHM had negative earnings in 4 of the past 5 years.
Each year in the past 5 years BHM had a positive operating cash flow.
BHM Yearly Net Income VS EBIT VS OCF VS FCFBHM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

BHM has a worse Return On Assets (-0.60%) than 60.00% of its industry peers.
The Return On Equity of BHM (-2.26%) is worse than 65.00% of its industry peers.
Industry RankSector Rank
ROA -0.6%
ROE -2.26%
ROIC N/A
ROA(3y)-0.42%
ROA(5y)2.73%
ROE(3y)-1.76%
ROE(5y)1.52%
ROIC(3y)N/A
ROIC(5y)N/A
BHM Yearly ROA, ROE, ROICBHM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

Looking at the Gross Margin, with a value of 42.83%, BHM is doing worse than 95.00% of the companies in the same industry.
BHM's Gross Margin has declined in the last couple of years.
BHM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.92%
GM growth 5YN/A
BHM Yearly Profit, Operating, Gross MarginsBHM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 200 -200 400 600

More info and screens

3

2. Health

2.1 Basic Checks

BHM does not have a ROIC to compare to the WACC, probably because it is not profitable.
BHM has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, BHM has a worse debt to assets ratio.
BHM Yearly Shares OutstandingBHM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
BHM Yearly Total Debt VS Total AssetsBHM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

BHM has an Altman-Z score of 0.13. This is a bad value and indicates that BHM is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.13, BHM is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.98 indicates that BHM is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.98, BHM is in line with its industry, outperforming 55.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC5.53%
BHM Yearly LT Debt VS Equity VS FCFBHM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 1.51 indicates that BHM should not have too much problems paying its short term obligations.
BHM has a better Current ratio (1.51) than 95.00% of its industry peers.
BHM has a Quick Ratio of 1.51. This is a normal value and indicates that BHM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BHM (1.51) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
BHM Yearly Current Assets VS Current LiabilitesBHM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M

More info and screens

3

3. Growth

3.1 Past

BHM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.01%.
BHM shows a strong growth in Revenue. In the last year, the Revenue has grown by 31.63%.
Measured over the past years, BHM shows a very strong growth in Revenue. The Revenue has been growing by 50.84% on average per year.
EPS 1Y (TTM)-43.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-146.94%
Revenue 1Y (TTM)31.63%
Revenue growth 3Y50.84%
Revenue growth 5YN/A
Sales Q2Q%46.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHM Yearly Revenue VS EstimatesBHM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHM Price Earnings VS Forward Price EarningsBHM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BHM indicates a rather expensive valuation: BHM more expensive than 95.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 49.42
BHM Per share dataBHM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.78%, BHM is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.70, BHM pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, BHM pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.78%

5.2 History

BHM does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BHM Yearly Dividends per shareBHM Yearly Dividends per shareYearly Dividends per share 2023 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BHM has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-90.13%
EPS Next 2YN/A
EPS Next 3YN/A
BHM Yearly Income VS Free CF VS DividendBHM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 100M -100M -200M

More info and screens

BLUEROCK HOMES TRUST INC

NYSEARCA:BHM (7/14/2025, 8:25:26 PM)

13.5

+0.21 (+1.58%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners34.04%
Inst Owner ChangeN/A
Ins Owners9.15%
Ins Owner Change0%
Market Cap54.95M
AnalystsN/A
Price TargetN/A
Short Float %0.17%
Short Ratio1.9
Dividend
Industry RankSector Rank
Dividend Yield 5.78%
Yearly Dividend1.87
Dividend Growth(5Y)N/A
DP-90.13%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-24 2025-12-24 (0.125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.99
P/FCF N/A
P/OCF 6.17
P/B 0.22
P/tB 0.22
EV/EBITDA 49.42
EPS(TTM)-1.49
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-57.31
FCFYN/A
OCF(TTM)2.19
OCFY16.2%
SpS13.62
BVpS62.37
TBVpS62.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -2.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.83%
FCFM N/A
ROA(3y)-0.42%
ROA(5y)2.73%
ROE(3y)-1.76%
ROE(5y)1.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.92%
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 48.15
Cap/Depr 953.58%
Cap/Sales 436.73%
Interest Coverage N/A
Cash Conversion 171.42%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 0.13
F-Score3
WACC5.53%
ROIC/WACCN/A
Cap/Depr(3y)728.9%
Cap/Depr(5y)962.54%
Cap/Sales(3y)349.98%
Cap/Sales(5y)565.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-146.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)31.63%
Revenue growth 3Y50.84%
Revenue growth 5YN/A
Sales Q2Q%46.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-66.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y383.5%
OCF growth 3Y-2.62%
OCF growth 5YN/A